Bruker
Company profile
Primary focus
Scientific instruments and analytical and diagnostic solutions for life sciences, materials science, semiconductor and applied markets.
Why it’s included
The company develops and manufactures the 'MALDI Biotyper sirius CA System,' an FDA-cleared high-throughput MALDI-TOF mass spectrometry platform for clinical microbial identification, and also offers sample preparation automation and LC-MS/LCMS sample prep solutions, directly matching the topic's requirements for clinical laboratory mass spectrometry systems.
Relevant capabilities
- Mass spectrometry platforms and workflows
- Native and top-down mass spectrometry with ion-mobility separation
Commercial sectorMALDI-TOF Microbial Identification Systems
Technology classesMALDI-TOF microbial identification from cultured isolates, Microbial spectral database construction and matching algorithms
Relevant commercial products
- MALDI Biotyper sirius CA System
- MALDI Biotyper sirius System
- MALDI Biotyper® Reference Libraries
- MBT Compass HT Software
- autoflex III spectrometer
Relevant patents
5 families, 5 publications- Analysis of microbes from microcolonies by maldi mass spectrometry US-8835176-B2
- Mass spectrometric diagnosis of septicemia US-11473122-B2
- Mass spectrometric diagnosis of sepsis without blood culture US-10597692-B2
- Mass spectrometric measurement of microbial resistances US-9051594-B2
- Analysis of microbes by MALDI mass spectrometry US-9171709-B2